BiondVax Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch BVXV and buy or sell other stocks, ETFs, and their options commission-free!

About BVXV

Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. 

CEO
Amir Reichman, MBA
CEOAmir Reichman, MBA
Employees
31
Employees31
Headquarters
Jerusalem, Jerusalem
HeadquartersJerusalem, Jerusalem
Founded
2003
Founded2003
Employees
31
Employees31

BVXV Key Statistics

Market cap
410.29K
Market cap410.29K
Price-Earnings ratio
-0.64
Price-Earnings ratio-0.64
Dividend yield
—
Dividend yield—
Average volume
13.91K
Average volume13.91K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$8.92
52 Week high$8.92
52 Week low
$2.23
52 Week low$2.23
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.